» Articles » PMID: 28203693

Complex Chromosomal Rearrangements by Single Catastrophic Pathogenesis in NUT Midline Carcinoma

Overview
Journal Ann Oncol
Publisher Elsevier
Specialty Oncology
Date 2017 Feb 17
PMID 28203693
Citations 33
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Nuclear protein in testis (NUT) midline carcinoma (NMC) is a rare aggressive malignancy often occurring in the tissues of midline anatomical structures. Except for the pathognomonic BRD3/4-NUT rearrangement, the comprehensive landscape of genomic alterations in NMCs has been unexplored.

Patients And Methods: We investigated three NMC cases, including two newly diagnosed NMC patients in Seoul National University Hospital, and a previously reported cell line (Ty-82). Whole-genome and transcriptome sequencing were carried out for these cases, and findings were validated by multiplex fluorescence in situ hybridization and using individual fluorescence probes.

Results: Here, we present the first integrative analysis of whole-genome sequencing, transcriptome sequencing and cytogenetic characterization of NUT midline carcinomas. By whole-genome sequencing, we identified a remarkably similar pattern of highly complex genomic rearrangements (previously denominated as chromoplexy) involving the BRD3/4-NUT oncogenic rearrangements in two newly diagnosed NMC cases. Transcriptome sequencing revealed that these complex rearrangements were transcribed as very simple BRD3/4-NUT fusion transcripts. In Ty-82 cells, we also identified a complex genomic rearrangement involving the BRD4-NUT rearrangement underlying the simple t(15;19) karyotype. Careful inspections of rearrangement breakpoints indicated that these rearrangements were likely attributable to single catastrophic events. Although the NMC genomes had >3000 somatic point mutations, canonical oncogenes or tumor suppressor genes were rarely affected, indicating that they were largely passenger events. Mutational signature analysis showed predominant molecular clock-like signatures in all three cases (accounting for 54%-75% of all base substitutions), suggesting that NMCs may arise from actively proliferating normal cells.

Conclusion: Taken together, our findings suggest that a single catastrophic event in proliferating normal cells could be sufficient for neoplastic transformation into NMCs.

Citing Articles

Targeted combination chemotherapy effective in nuclear protein in testis carcinoma of lung origin: A case report and review of the literature.

Li R, Zhang Y, Liu Q, Gao A, Dang Q Medicine (Baltimore). 2025; 103(52):e38881.

PMID: 39969296 PMC: 11688100. DOI: 10.1097/MD.0000000000038881.


Hiding in plain sight: NUT carcinoma is an unrecognized subtype of squamous cell carcinoma of the lungs and head and neck.

Luo J, Bishop J, Dubois S, Hanna G, Sholl L, Stelow E Nat Rev Clin Oncol. 2025; .

PMID: 39900969 DOI: 10.1038/s41571-025-00986-3.


Epigenetics-targeted drugs: current paradigms and future challenges.

Dai W, Qiao X, Fang Y, Guo R, Bai P, Liu S Signal Transduct Target Ther. 2024; 9(1):332.

PMID: 39592582 PMC: 11627502. DOI: 10.1038/s41392-024-02039-0.


Multiomic Characterization and Molecular Profiling of Nuclear Protein in Testis Carcinoma.

Kroening G, Luo J, Evans M, Adeyelu T, Ou S, Arter Z JCO Precis Oncol. 2024; 8:e2400334.

PMID: 39447095 PMC: 11520346. DOI: 10.1200/PO.24.00334.


[NUT cancer of nasal cavity and sinuses: a case report and literature review].

Wang Y, Zhao J, Zhou X, Liu J Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2024; 38(6):530-533.

PMID: 38858120 PMC: 11480580. DOI: 10.13201/j.issn.2096-7993.2024.06.014.


References
1.
Grayson A, Walsh E, Cameron M, Godec J, Ashworth T, Ambrose J . MYC, a downstream target of BRD-NUT, is necessary and sufficient for the blockade of differentiation in NUT midline carcinoma. Oncogene. 2013; 33(13):1736-1742. PMC: 3942361. DOI: 10.1038/onc.2013.126. View

2.
French C, Ramirez C, Kolmakova J, Hickman T, Cameron M, Thyne M . BRD-NUT oncoproteins: a family of closely related nuclear proteins that block epithelial differentiation and maintain the growth of carcinoma cells. Oncogene. 2007; 27(15):2237-42. DOI: 10.1038/sj.onc.1210852. View

3.
Kees U, Mulcahy M, WILLOUGHBY M . Intrathoracic carcinoma in an 11-year-old girl showing a translocation t(15;19). Am J Pediatr Hematol Oncol. 1991; 13(4):459-64. DOI: 10.1097/00043426-199124000-00011. View

4.
Reynoird N, Schwartz B, Delvecchio M, Sadoul K, Meyers D, Mukherjee C . Oncogenesis by sequestration of CBP/p300 in transcriptionally inactive hyperacetylated chromatin domains. EMBO J. 2010; 29(17):2943-52. PMC: 2944051. DOI: 10.1038/emboj.2010.176. View

5.
French C, Miyoshi I, Kubonishi I, Grier H, Perez-Atayde A, Fletcher J . BRD4-NUT fusion oncogene: a novel mechanism in aggressive carcinoma. Cancer Res. 2003; 63(2):304-7. View